Clover Biopharmaceuticals has ended its partnership with GlaxoSmithKline Plc (GSK.L) to develop a COVID-19 vaccine using its adjuvant, the Chinese drugmaker said on Monday, as it will stick with a ...
U.S. insurance startup Clover Health will go public through a merger with blank-check firm Social Capital Hedosophia Holdings Corp III in a deal valued at $3.7 billion including debt, the company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback